AMETEK Brookfield’s Computrac Vapor Pro XL Autosampler Offers Moisture-Specific Analysis Technology
The compact device is suited for applications that require test automation and increased throughput and provides a chemical-free substitute for Karl Fischer titration.
Computrac Vapor Pro XL Autosampler from AMETEK Brookfield, part of AMETEK's Instrumentation and Specialty Controls Division, aims to increase the efficiency of the Vapor Pro’s moisture-specific analysis technology by analyzing up to 16 samples automatically with individual test profiles.
The compact device is suited for applications that require test automation and increased throughput and provides a chemical-free substitute for Karl Fischer titration. Additionally, it provides testing for applications in the pharmaceuticals industry as well as in other industries (food, lubricants, paints and coatings, plastics, and batteries).
"Busy quality managers will enjoy peace-of-mind and boosted productivity with an automated moisture analysis of up to 16 product samples," said Kai Johnstad, AMETEK Brookfield's global product manager, in a Nov. 25, 2020 press release. "Product stakeholders will also benefit from time and cost savings by ensuring the perfect moisture content without using Karl Fischer titration."
Source: AMETEK Brookfield
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
